Interstitial Lung Disease in Rheumatoid Arthritis

Author(s): Kristine Phillips, Kevin R. Flaherty, Eric L. Matteson, Tim Bongartz, Joan Bathon, Kevin K. Brown, Paul F. Dellaripa

Journal Name: Current Rheumatology Reviews

Volume 6 , Issue 2 , 2010

Become EABM
Become Reviewer


Rheumatoid arthritis (RA) affects 1-2% of the general population. Although often thought of as primarily a localized inflammatory disorder with associated joint destruction, it is a diffuse systemic disease. Extra-articular manifestations of rheumatoid arthritis can be demonstrated in almost 50% of patients with RA, and include pulmonary, cardiac, ocular, renal, hematologic, and neurologic involvement. In this article, we review recent studies of interstitial lung disease (ILD) in RA with a focus on clinical and pathological features of rheumatoid arthritis associated interstitial lung disease (RA-ILD). We discuss an approach to the diagnosis and treatment of RA-ILD including potential biomarkers, and conclude by outlining areas for future research.

Keywords: Rheumatoid arthritis, interstitial lung disease, pulmonary fibrosis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [120 - 126]
Pages: 7
DOI: 10.2174/157339710791330696
Price: $65

Article Metrics

PDF: 11